344 related articles for article (PubMed ID: 25409185)
21. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
22. Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
Zong H; Cao L; Ma C; Zhao J; Ming X; Shang M; Xu H
Tumour Biol; 2014 Aug; 35(8):8095-101. PubMed ID: 24840634
[TBL] [Abstract][Full Text] [Related]
23. CCND1 G870A polymorphism is associated with increased risk of colorectal cancer, especially for sporadic colorectal cancer and in Caucasians: a meta-analysis.
Yang J; Zhang G; Chen J
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):169-77. PubMed ID: 22322158
[TBL] [Abstract][Full Text] [Related]
24. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
[TBL] [Abstract][Full Text] [Related]
25. CCND1 G870A polymorphism and risk for head and neck cancer: a meta-analysis.
Tang C; Wang Z; Yu J; Wu Y; Zhu Z; Chen N
Med Oncol; 2011 Dec; 28(4):1319-24. PubMed ID: 20443083
[TBL] [Abstract][Full Text] [Related]
26. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J
Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185
[TBL] [Abstract][Full Text] [Related]
28. CCND1 G870A polymorphism contributes to the risk of esophageal cancer: An updated systematic review and cumulative meta-analysis.
Wen L; Hu YY; Yang GL; Liu DX
Biomed Rep; 2014 Jul; 2(4):549-554. PubMed ID: 24944806
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.
Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z
DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692
[TBL] [Abstract][Full Text] [Related]
30. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis.
Tan XL; Nieters A; Kropp S; Hoffmeister M; Brenner H; Chang-Claude J
Int J Cancer; 2008 Jun; 122(11):2573-80. PubMed ID: 18196581
[TBL] [Abstract][Full Text] [Related]
31. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
[TBL] [Abstract][Full Text] [Related]
32. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
33. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
Cancer Invest; 2012 Nov; 30(9):630-6. PubMed ID: 23020291
[TBL] [Abstract][Full Text] [Related]
35. The CCND1 G870A polymorphism and susceptibility to bladder cancer.
Li J; Luo F; Zhang H; Li L; Xu Y
Tumour Biol; 2014 Jan; 35(1):171-7. PubMed ID: 23893383
[TBL] [Abstract][Full Text] [Related]
36. [Cyclin D1 gene G870A polymorphism and susceptibility to nasopharyngeal carcinoma].
Sui J; Gao W; Li XJ; Ma J; Ren YX; Song X; Xiao CJ; Tang WR
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):227-31. PubMed ID: 19558863
[TBL] [Abstract][Full Text] [Related]
37. CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.
Xu XM; Ni XB; Yang GL; Luo ZG; Niu YM; Shen M
Mol Clin Oncol; 2016 Jun; 4(6):1078-1084. PubMed ID: 27284448
[TBL] [Abstract][Full Text] [Related]
38. The cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.
Zhang LQ; Huang XE; Wang J; Shang JQ; Bai J; Liu FY; Guan X; Zhou JN
Asian Pac J Cancer Prev; 2011; 12(1):81-5. PubMed ID: 21517236
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.
Yang Y; Wang F; Shi C; Zou Y; Qin H; Ma Y
PLoS One; 2012; 7(5):e36813. PubMed ID: 22606291
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]